Eli LillyLǐlái礼来withyǔ与Insilico Medicine, an AI drug R&D companyInsilico MedicineInsilico Medicineto signqiānshǔ签署$2.75 billionèrshíqī diǎn wǔ yì měiyuán27.5亿美元artificial intelligenceAIAInew drugxīnyào新药developmentkāifā开发agreementxiéyì协议。
Eli Lilly
Lǐlái
礼来
with
yǔ
与
Insilico Medicine, an AI drug R&D company
Insilico Medicine
Insilico Medicine
to sign
qiānshǔ
签署
$2.75 billion
èrshíqī diǎn wǔ yì měiyuán
27.5亿美元
artificial intelligence
AI
AI
new drug
xīnyào
新药
development
kāifā
开发
agreement
xiéyì
协议
United States
Měiguó
美国
pharmaceutical
zhìyào
制药
company
gōngsī
公司
Eli Lilly
Lǐlái
礼来
with
yǔ
与
Hong Kong
Xiānggǎng
香港
artificial intelligence
AI
AI
drug
yàowù
药物
research and development
yánfā
研发
company
gōngsī
公司
Insilico Medicine
Insilico Medicine
Insilico Medicine
to sign
qiānshǔ
签署
completion particle
le
了
an
yī xiàng
一项
up to
zuìgāo
最高
$2.75 billion
èrshíqī diǎn wǔ yì měiyuán
27.5亿美元
structural particle
de
的
cooperation agreement
hézuò xiéyì
合作协议
Eli Lilly
Lǐlái
礼来
will
jiāng
将
to obtain
huòdé
获得
in
zài
在
global
quánqiú
全球
to develop
kāifā
开发
and
hé
和
to sell
xiāoshòu
销售
AI
AI
AI
designed
shèjì
设计
oral
kǒufú
口服
drug
yàowù
药物
structural particle
de
的
exclusive
dújiā
独家
license / authorization
shòuquán
授权
March 29, 2026 at 10:00 PM
United States
Měiguó
美国
pharmaceutical
zhìyào
制药
company
gōngsī
公司
Eli Lilly
Lǐlái
礼来
to announce
xuānbù
宣布
with
yǔ
与
Hong Kong
Xiānggǎng
香港
artificial intelligence
AI
AI
drug
yàowù
药物
R&D
yánfā
研发
company
gōngsī
公司
Insilico Medicine
Insilico Medicine
Insilico Medicine
to reach
dáchéng
达成
cooperation
hézuò
合作
agreement
xiéyì
协议
agreement
xiéyì
协议
total value
zǒng jiàzhí
总价值
up to a maximum of
zuìgāo
最高
can reach
kě dá
可达
$2.75 billion
èrshíqī diǎn wǔ yì měiyuán
27.5亿美元
according to
gēnjù
根据
the agreement
xiéyì
协议
Insilico Medicine
Insilico Medicine
Insilico Medicine
will
jiāng
将
first
shǒuxiān
首先
to receive
huòdé
获得
$115 million
yī diǎn yī wǔ yì měiyuán
1.15亿美元
upfront payment
yùfùkuǎn
预付款
the remaining
qíyú
其余
payments
kuǎnxiàng
款项
will
jiāng
将
based on
gēnjù
根据
R&D
yánfā
研发
and
hé
和
commercial
shāngyè
商业
milestone
lǐchéngbēi
里程碑
to pay
zhīfù
支付
with additional
lìng fù
另附
sales
xiāoshòu
销售
royalty
tíchéng
提成
Eli Lilly
Lǐlái
礼来
to obtain
huòdé
获得
completion particle
le
了
for
zài
在
global
quánqiú
全球
to develop
kāifā
开发
and
hé
和
to sell
xiāoshòu
销售
AI
AI
AI
designed
shèjì
设计
oral
kǒufú
口服
drug
yàowù
药物
structural particle
de
的
exclusive
dújiā
独家
authorization
shòuquán
授权
Insilico Medicine
Insilico Medicine
Insilico Medicine
to use
shǐyòng
使用
named
míng wéi
名为
Pharma.AI, an AI drug discovery platform
Pharma.AI
Pharma.AI
structural particle
de
的
platform
píngtái
平台
to
lái
来
to discover
fāxiàn
发现
new drug
xīnyào
新药
the company
gāi gōngsī
该公司
already
yǐ
已
using
yòng
用
AI
AI
AI
tools
gōngjù
工具
developed
yánfā
研发
completion particle
le
了
at least
zhìshǎo
至少
28 types of
èrshíbā zhǒng
28种
new drug
xīnyào
新药
nearly half
jìn yī bàn
近一半
already
yǐ
已
to enter
jìnrù
进入
clinical
línchuáng
临床
phase
jiēduàn
阶段
the two
liǎng jiā
两家
companies
gōngsī
公司
since
zì
自
the year 2023
èr líng èr sān nián
2023年
starting from
qǐ
起
have had
yǐ yǒu
已有
cooperation
hézuò
合作
relationship
guānxi
关系
this
cǐ cì
此次
deal
hézuò
合作
shows
xiǎnshì chū
显示出
pharmaceutical
zhìyào
制药
industry
hángyè
行业
toward
duì
对
AI
AI
AI
technology
jìshù
技术
structural particle
de
的
investment
tóurù
投入
increasingly
rìyì
日益
increasing
zēngjiā
增加
New Words
kēxué
科学
science
yánjiū
研究
research
fāxiàn
发现
discovery
shíyàn
实验
experiment
shùjù
数据
data
fēnxī
分析
analysis
chéngguǒ
成果
achievement
jìnzhǎn
进展
progress
tūpò
突破
breakthrough
yìngyòng
应用
application
News in English
BusinessEli Lilly Signs $2.75 Billion Deal With Insilico for AI-Developed Drugs
Eli Lilly signed a deal worth up to $2.75 billion with Hong Kong AI drug company Insilico Medicine, granting Lilly exclusive global rights to develop and sell AI-designed oral drugs.
Scientific research and discovery report covering advances in various academic fields.
More in Business
Chinazhōngguó中国planjìhuà计划20262026 nián2026年artificial intelligenceAIAIchipxīnpiàn芯片production capacitychǎnéng产能triplefān sānbèi翻三倍。
China
zhōngguó
中国
plan
jìhuà
计划
2026
2026 nián
2026年
artificial intelligence
AI
AI
chip
xīnpiàn
芯片
production capacity
chǎnéng
产能
triple
fān sānbèi
翻三倍
China Targets Tripling AI Chip Production in 2026 to Counter Nvidia Dependence
Chinazhōngguó中国artificial intelligenceAIAIchipxīnpiàn芯片manufacturerszhìzàoshāng制造商revenueyíngshōu营收significantlydàfú大幅growzēngzhǎng增长。
China
zhōngguó
中国
artificial intelligence
AI
AI
chip
xīnpiàn
芯片
manufacturers
zhìzàoshāng
制造商
revenue
yíngshōu
营收
significantly
dàfú
大幅
grow
zēngzhǎng
增长
Chinese AI Chipmakers Report Soaring Revenue Growth in 2026 Earnings Season
United States / AmericanMěiguó美国July7 yuè7月Consumer Price Index (CPI)CPICPIonly / merelyjǐn仅to rise / to go upshēng升0.1 percent0.1%0.1%，interest rate hikejiā xī加息worry / concerndānyōu担忧to ease / to alleviatehuǎnjiě缓解。
United States / American
Měiguó
美国
July
7 yuè
7月
Consumer Price Index (CPI)
CPI
CPI
only / merely
jǐn
仅
to rise / to go up
shēng
升
0.1 percent
0.1%
0.1%
interest rate hike
jiā xī
加息
worry / concern
dānyōu
担忧
to ease / to alleviate
huǎnjiě
缓解
US July CPI Rises Just 0.1 Percent as Tame Inflation Data Boosts Markets
Trian Fund Management (investment firm)Tèlǐān Jījīn特里安基金to plan / planjìhuà计划to acquire / takeovershōugòu收购Wendys (fast-food chain)Wēndí温迪，stock pricegǔjià股价to rise / to go upshàngzhǎng上涨13 percent13%13%。
Trian Fund Management (investment firm)
Tèlǐān Jījīn
特里安基金
to plan / plan
jìhuà
计划
to acquire / takeover
shōugòu
收购
Wendys (fast-food chain)
Wēndí
温迪
stock price
gǔjià
股价
to rise / to go up
shàngzhǎng
上涨
13 percent
13%
13%
Trian Fund Prepares Bid to Take Wendys Private as Stock Jumps 13 Percent